MEGAN DUPRE: Open Payments
NPI 1851821326 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 36 payments from 9 companies in 2025. Trend: 2023 $975 · 2024 $885 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $210 |
| ABBVIE INC. | 13 | $186 |
| Lilly USA, LLC | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| PFIZER INC. | 2 | $31 |
| Dexcom, Inc. | 1 | $20 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Wegovy, CREON, UBRELVY, ZEPBOUND, Ozempic, AIRSUPRA, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
